James Parslow
2019
In 2019, James Parslow earned a total compensation of $387.8K as Chief Financial Officer at Xenetic Biosciences, a 35% increase compared to previous year.
Compensation breakdown
| Option Awards | $99,857 |
|---|---|
| Salary | $265,000 |
| Other | $22,963 |
| Total | $387,820 |
Parslow received $265K in salary, accounting for 68% of the total pay in 2019.
Parslow also received $99.9K in option awards and $23K in other compensation.
Rankings
In 2019, James Parslow's compensation ranked 12,426th out of 13,971 executives tracked by ExecPay. In other words, Parslow earned more than 11.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,426 out of 13,971 | 11th |
Division Manufacturing | 5,020 out of 5,695 | 12th |
Major group Chemicals And Allied Products | 1,975 out of 2,194 | 10th |
Industry group Drugs | 1,699 out of 1,880 | 10th |
Industry Pharmaceutical Preparations | 1,258 out of 1,392 | 10th |
Source: SEC filing on October 13, 2020.
Parslow's colleagues
We found two more compensation records of executives who worked with James Parslow at Xenetic Biosciences in 2019.